You are here:

International Course on the Clinical and Programmatic Management of Drug-Resistant Tuberculosis 2023

Published on


4-8 December 2023

Hybrid course


This course is being organized by The Union in partnership with Wan Fang Hospital, Taipei Medical University and Taiwan Anti-Tuberculosis Association.

UPDATE: this course has been rescheduled to December 2023.

The International Course on the Clinical and Programmatic Management of Drug-Resistant Tuberculosis will be delivered as a hybrid: online and in-person course consisting of online  materials and a 5-day in-person session in Taipei (Taiwan).

The online course includes on-demand videos and quizzes, aiming to strengthen participants’ capacity in the clinical and programmatic management of drug-resistant tuberculosis. The online course materials are optional but recommended as preparation for the in-person session.

The in-person session includes revision of the topics covered by the online materials, Q&As with faculty, updates not included in the online materials and time to discuss difficult cases and challenges. The in-person session will also include a visit to the Taiwan CDC. The in-person session will take place from the 4th to the 8th December 2023.

The 2023 edition of the course includes the latest WHO guidelines and the latest research findings, as well as considerations about implementation in limited-resource settings.

The course will be delivered to a group of 20 participants.

Course Objectives

At the end of this course, participants will be able to:

  • Describe the current global epidemiological situation of drug-resistant tuberculosis
  • Describe the different approaches for the detection and diagnosis of drug-resistant tuberculosis
  • Address the principles of  treatment and regimen design, according to different patterns of drug-resistance
  • Review key second line and new anti-tuberculosis medicines
  • Discuss common problems and possible solutions for programmatic management of drug-resistant tuberculosis

Course Brief

Who Should Attend

This course is designed for clinicians, who are responsible for diagnosis and treatment of drug-resistant tuberculosis, staff of national tuberculosis programmes and technical partners, working in tuberculosis care and prevention, in low- and middle-income countries, especially in settings where programmatic management of drug-resistant tuberculosis (PMDT) had been or is going to be implemented.

Course Fee: 1,300 EUR for the course fees only or 2,200 EUR for course fee and accommodation package. Payable via credit card or international bank transfer. 

The course fee includes:

  • Unlimited access to the online course materials
  • Five-day in-person sessions Taipei
  • Lunch and coffee breaks during the in-person session

The accommodation package includes up to 6 nights accommodation in a hotel near the training venue.

Course Directors

  • Dr Chen-Yuan Chiang

Language: English


The in-person session will take place in Taipei (Taiwan), from the 4 to the 8 December 2023.


To complete your registration, you will need to submit a CV and the details of your sponsor or the person paying for the course fees, so we can issue an invoice.


Unfortunately, The Union does not have funding to offer scholarships to attend this course. We encourage participants to find a sponsor locally.